Last updated: 2026-10-12 17:03:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Edwards Lifesciences Corp. (EW) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NYSE. The stock is currently priced at $85.58, with a market capitalization of $49.12B and a P/E ratio of 48.88. Over the past 52 weeks, its price has ranged from $72.30 to $96.29. This page covers its latest market performance, valuation, price trends and company information.
$49.12B | |
$85.24 | |
$131.73 | |
$2.23 | |
$85.21 | |
1.32M | |
3.85M | |
48.88 | |
$96.29 | |
$72.30 | |
-- | |
-- |
Edwards Lifesciences Corp. (EW) is currently trading at $85.58 as of 2026-10-12 16:46:56, up 0.43% ($0.37) from the previous close of $85.21
During today's regular trading session, EW has traded between $2.23 and $131.73, with a trading volume of 1.32M shares. The current price is near the middle of today's range.
Over the past seven days, Edwards Lifesciences Corp. (EW) moved from $85.19 to $85.58, representing a gain of 0.45% ($0.39).
The stock traded between $82.43 and $87.88 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 3.73 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 55.3%
EW is currently trading at $85.58, placing it 55.3% of the way from its 52-week low of $72.30 to its 52-week high of $96.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 16000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Edwards Lifesciences Corp. (EW) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.